Bamco Inc. NY grew its holdings in Teleflex Incorporated (NYSE:TFX) by 38.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 189,785 shares of the medical technology company’s stock after acquiring an additional 52,645 shares during the quarter. Bamco Inc. NY’s holdings in Teleflex were worth $47,222,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Comerica Bank boosted its position in shares of Teleflex by 0.6% in the fourth quarter. Comerica Bank now owns 35,546 shares of the medical technology company’s stock valued at $9,778,000 after acquiring an additional 198 shares during the period. Chartwell Investment Partners LLC boosted its position in shares of Teleflex by 3.9% in the third quarter. Chartwell Investment Partners LLC now owns 5,444 shares of the medical technology company’s stock valued at $1,317,000 after acquiring an additional 204 shares during the period. Creative Planning boosted its position in shares of Teleflex by 6.0% in the fourth quarter. Creative Planning now owns 4,119 shares of the medical technology company’s stock valued at $1,025,000 after acquiring an additional 234 shares during the period. Osterweis Capital Management Inc. lifted its position in Teleflex by 0.3% in the fourth quarter. Osterweis Capital Management Inc. now owns 90,707 shares of the medical technology company’s stock worth $22,570,000 after purchasing an additional 242 shares during the period. Finally, Barometer Capital Management Inc. lifted its position in Teleflex by 3.2% in the fourth quarter. Barometer Capital Management Inc. now owns 8,075 shares of the medical technology company’s stock worth $2,009,000 after purchasing an additional 250 shares during the period. 89.79% of the stock is owned by institutional investors.
Teleflex Incorporated (NYSE:TFX) opened at $269.26 on Friday. The company has a market capitalization of $11,606.94, a price-to-earnings ratio of 82.34, a P/E/G ratio of 1.90 and a beta of 1.22. Teleflex Incorporated has a 12-month low of $191.04 and a 12-month high of $288.78. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.33 and a quick ratio of 1.51.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Friday, March 2nd will be paid a dividend of $0.34 per share. The ex-dividend date is Thursday, March 1st. This represents a $1.36 annualized dividend and a yield of 0.51%. Teleflex’s dividend payout ratio is currently 41.59%.
In other Teleflex news, VP John Deren sold 1,359 shares of the stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $255.67, for a total transaction of $347,455.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $248.96, for a total value of $49,792.00. Following the transaction, the director now owns 8,080 shares of the company’s stock, valued at $2,011,596.80. The disclosure for this sale can be found here. Insiders have sold 11,759 shares of company stock valued at $3,089,211 over the last quarter. Corporate insiders own 2.39% of the company’s stock.
Several research analysts recently commented on TFX shares. Piper Jaffray Companies started coverage on Teleflex in a research report on Friday, November 10th. They issued an “overweight” rating and a $295.00 target price for the company. Deutsche Bank cut Teleflex from a “buy” rating to a “hold” rating and set a $251.00 target price for the company. in a research report on Tuesday, November 14th. ValuEngine cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Stephens reaffirmed a “buy” rating and issued a $300.00 target price on shares of Teleflex in a research report on Thursday, January 18th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $321.00 target price (up from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. Teleflex has an average rating of “Hold” and a consensus target price of $281.56.
COPYRIGHT VIOLATION NOTICE: “Bamco Inc. NY Boosts Stake in Teleflex Incorporated (TFX)” was published by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3252521/bamco-inc-ny-boosts-stake-in-teleflex-incorporated-tfx.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.